Preferential induction of apoptosis by interferon (IFN)-β compared with IFN-α2: Correlation with TRAIL/Apo2L induction in melanoma cell lines

Clinical Cancer Research

Volumn 7, Issue 6, 2001, Pages 1821-1831

  Chawla Sarkar, M ^a   Leaman, D W ^a   Borden, E C ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BETA INTERFERON; BETA1A INTERFERON; CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; DNA FRAGMENT; LIPOCORTIN 5; NEUTRALIZING ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RECOMBINANT ALPHA2B INTERFERON; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; GENE INDUCTION; HUMAN; HUMAN CELL; MELANOMA CELL; NICK END LABELING; PRIORITY JOURNAL;

ANNEXIN A5; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL DIVISION; CYTOCHROME C GROUP; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; INTERFERON-ALPHA; INTERFERON-BETA; MELANOMA; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; POLY(ADP-RIBOSE) POLYMERASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASES; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034895641     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. How cells respond to interferons
2. Biologic properties of recombinant αinterferons: 40th anniversary of the discovery of interferons
3. Interferons
4. 0-like arrest
5. The comparative antiproliferative activity in vitro of natural interferons α and β for diploid and transformed human cells
6. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony forming assay
7. Growth inhibitory effects of interferon-β but not interferon-α on human glioma cells: Correlation of receptor binding 2′,5′-oligoadenylate synthetase and protein kinase activity
8. Antiproliferative potencies of interferons on melanoma cell lines and xenografts: Higher efficacy of interferon β
9. Specific immunoreactivity of hybridoma-secreted monoclonal antimelanoma antibodies to cultured cells and freshly derived human cells
10. New colorimetric cytotoxicity assay for anticancer drug screening
11. A mutant cell line defective in response to double-stranded RNA and in regulating basal expression of interferon-stimulated genes
12. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro
13. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
14. Induction of apoptosis and inhibition of cell growth are independent responses to interferon-α in hematopoietic cell lines
15. Human myeloma cell apoptosis induced by interferon-α
16. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia
17. Regression of basal cell carcinoma by intralesional interferon-α treatment is mediated by CD95 (Apo-I/Fas)-CD95 ligand-induced suicide
18. Interferon α receptor expression and growth inhibition by interferon α in human liver cancer cell lines
19. Effect of natural interferon-β on the growth of melanoma cell lines
20. Induction of apoptosis in cultured colon cancer cells by transfection with human interferon β gene
21. Induction of apoptotic cell death by IFN β on HPV-16-transformed human keratinocytes
22. Interferon-α inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells
23. Distinct stages of cytochrome c release from mitochondria: Evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis
24. Proteases to die for
25. Interferon action and apoptosis are defective in mice devoid of 2′, 5′-oligoadenylate-dependent RNase L
26. Recombinant IFN-α (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells
27. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
28. IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STATprotein for up-regulation of Fas and FasL expression
29. Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression
30. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal
31. p53-independent up-regulation of KILLER/DR5 TRAIL receptor by glucocorticoids and interferon-γ
32. Safety and antitumor activity of recombinant soluble Apo2 ligand
33. Intracellular regulation of TRAIL- induced apoptosis in human melanoma cells
34. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
35. Apo2 Ligand/TNF-related apoptosis inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells
36. + T cells kill melanoma cells by mechanisms that are independent of Fas (CD95)
37. + T-cell killing of target cells
38. Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses
39. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-β